Open Access iconOpen Access

VIEWPOINT

Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients

SONIA MORETTI, FLAVIA MANCINI, ALESSANDRA BORSETTI*

National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, 00161, Italy

* Corresponding Author: ALESSANDRA BORSETTI. Email: email

BIOCELL 2022, 46(12), 2695-2699. https://doi.org/10.32604/biocell.2022.022257

Abstract

Direct-acting antiviral (DAA) therapies are efficacious for the achievement of sustained virologic response (SVR) in almost all treated hepatitis C virus (HCV)-infected patients. However, the impacts of HCV eradication on immune function and chronic immune activation in the long-term remain controversial and limited, especially in patients co-infected with human immunodeficiency virus (HIV). Indeed, although restoration of many immune responses clearly can be observed, several features of immune perturbations persist over time after HCV clearance. Understanding the degree and reasons of the partial recovery of the immune system in chronic HCV/HIV co-infection after HCV elimination is pivotal to avoid disease progression and possible long-term clinical outcomes in cured patients, as well as contributing to the development of immunotherapy drug design.

Keywords


Cite This Article

APA Style
MORETTI, S., MANCINI, F., BORSETTI, A. (2022). Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients. BIOCELL, 46(12), 2695-2699. https://doi.org/10.32604/biocell.2022.022257
Vancouver Style
MORETTI S, MANCINI F, BORSETTI A. Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients. BIOCELL . 2022;46(12):2695-2699 https://doi.org/10.32604/biocell.2022.022257
IEEE Style
S. MORETTI, F. MANCINI, and A. BORSETTI "Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients," BIOCELL , vol. 46, no. 12, pp. 2695-2699. 2022. https://doi.org/10.32604/biocell.2022.022257



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 860

    View

  • 517

    Download

  • 0

    Like

Share Link